A strategy for low-cost portable monitoring of plasma drug concentrations using a sustainable boron-doped-diamond chip

Takuro Saiki,Genki Ogata,Seishiro Sawamura,Kai Asai,Olga Razvina,Kota Watanabe,Rito Kato,Qi Zhang,Koei Akiyama,Sasya Madhurantakam,Norzahirah Binti Ahmad,Daisuke Ino,Haruma Nashimoto,Yoshifumi Matsumoto,Masato Moriyama,Arata Horii,Chie Kondo,Ryosuke Ochiai,Hiroyuki Kusuhara,Yasuo Saijo,Yasuaki Einaga,Hiroshi Hibino
DOI: https://doi.org/10.1016/j.heliyon.2023.e15963
IF: 3.776
2023-05-09
Heliyon
Abstract:On-site monitoring of plasma drug concentrations is required for effective therapies. Recently developed handy biosensors are not yet popular owing to insufficient evaluation of accuracy on clinical samples and the necessity of complicated costly fabrication processes. Here, we approached these bottlenecks via a strategy involving engineeringly unmodified boron-doped diamond (BDD), a sustainable electrochemical material. A sensing system based on a ∼1 cm2 BDD chip, when analysing rat plasma spiked with a molecular-targeting anticancer drug, pazopanib, detected clinically relevant concentrations. The response was stable in 60 sequential measurements on the same chip. In a clinical study, data obtained with a BDD chip were consistent with liquid chromatography-mass spectrometry results. Finally, the portable system with a palm-sized sensor containing the chip analysed ∼40 μL of whole blood from dosed rats within ∼10 min. This approach with the 'reusable' sensor may improve point-of-monitoring systems and personalised medicine while reducing medical costs.
What problem does this paper attempt to address?